Marktgröße und Marktanteil verschreibungspflichtiger Medikamente gegen Fettleibigkeit bis 2025 – 2031
Anti-Obesity Prescription Drugs Market Report Analysis
Anti-Obesity Prescription Drugs Market
-
CAGR (2025 - 2031)26% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- BRISTOL-MYERS SQUIBB CO.
- TAKEDA PHARMACEUTICAL
- EISAI COMPANY
- GLAXOSMITHKLINE PLC
- PFIZER INC
- SHIONOGI USA INC
- VIVUS INC
- ZAFGEN INC
- NORGINE BV
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Wirkmechanismus
- peripher wirkende Medikamente
- zentral wirkende Medikamente
By Arzneimittelklasse
- Bupropion und Naltrexon
- Orlistat
- Lorcaserin
- Phentermin und Topiramat
- Liraglutid
By Vertriebskanal
- Krankenhausapotheke
- Einzelhandelsapotheke
- Online-Apotheke
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Get Free Sample For